STX6 is upregulated in a variety of cancers including breast, colon, liver, pancreatic, prostate, bladder, skin, testicular, tongue, cervical, lung, and gastric cancers, and it has been identified as a common transcriptional target of the p53 family members (p53, p63, and p73) [89]. This evidence concerns the gene TP53 and cancer.